You've got just a few days left to submit your proposal to join us as a new Group Leader
📅 Applications close 2nd November
Package includes:
🪙Multi-year funding
🧪Core Facility Access
🥼 #Postdoc & #PhD positions
🤝Mentorship
Visit our website to apply:
www.cruk.manchester.ac.uk/career/new-g...
Along with this example from @cruk-ci.bsky.social, we contributed to the recent @crukpolicy.bsky.social report on how UK immigration policy is negatively affecting international recruitment of cancer researchers
Read the full story in @theobserveruk.bsky.social here: observer.co.uk/news/nationa...
@alexdickinson, not on Bluesky, on the concerns he has about the performance of the Grail Bio $GRAL MCED Galleri test
Online now! Cell-free DNA #methylome and #fragmentome analysis for relapse monitoring of #EwingSarcoma
By S. Richardson, M. McCabe, @florentmouliere.bsky.social & colleagues @cancerresearchuk.org @manchester.ac.uk
➡️ doi.org/10.1038/s44321-026-00396-7
Do you know anyone keen to study cancers of unmet need and understand how to improve their responses to treatment? We are looking for a curious enthusiastic scientific officer to work at @cruknbc.bsky.social , close ties with @manchester.ac.uk and @christieinstitute.bsky.social
Almost 2️⃣ years in…
Our MANIFEST AGM convened scientists, clinicians, patient partners & industry. Keynotes from Prof Levesque & Prof Rattray + Prof Turajlić setting the course ahead.
Big thank you to all for continuing to believe in the vision; to tackle the hard questions in #CancerImmunotherapy.
I am excited to share our review in Nature Reviews Genetics. Liquid biopsy are becoming better, smaller, faster and smarter. This next generation of #liquidbiopsy, #cfDNA multi-modal assays is unlocking applications in MCED, MRD, toxicity, functional and biological analysis of cancers, and beyond.
Cancer Research UK Manchester Institute
Cancer Research UK Manchester Institute
Exciting conference alert!
sites.manchester.ac.uk/from-lab-to-...
Fantastic speakers including Chris Marine, Christian Blank
Melanoma evolution
Local microenvironment of melanoma
Melanoma-host interactions
Precision immunotherapy
Emerging therapeutics
Clinical trials and real-world data
Florent Mouliere
EMBO Molecular Medicine
Sara Valpione 🌻
Albert Vilella, PhD.
The Lee lab is expanding! We are really interested in mechanisms of local and systemic immune tolerance particularly in liver metastases - X2 research technicians
💡 Creative fun environment
🌱 Opportunities to grow
🫂 Highly collaborative with clinical+basic research
📢 Please spread word!
Pleased to share results from the CAcTUS Phase II trial of ctDNA-guided therapy in BRAF-mutant advanced melanoma are now published! 🌵🧬
CAcTUS is the first melanoma trial to adapt treatment based on ctDNA testing.
Read: www.nature.com/articles/s41...
Targeted therapy (with BRAK and MEK inhibitors) and immune checkpoint blockade have improved survival for patients with advanced BRAF-mutant cutaneous melanoma, however, the optimal scheduling for the...
www.nature.com
Becki Lee
Becki Lee
Becki Lee
Video
With vital studies being shelved and foreign experts turning down jobs, leading charity urges ministers to act
